Video

ReciBioPharm Capacity Update May 2024: Cell & Gene Therapy

Source: ReciBioPharm

ReciBioPharm is a flexible, transparent, and end-to-end advanced therapies CDMO that goes beyond capacity. Learn more about ReciBioPharm’s global capabilities in Nucleic Acid (xRNA:LNP), AAV, Lentivirus, Microbiome and Fill-Finish. We offer end-to-end GMP manufacturing under one roof through an integrated supply chain from upstream to fill-finish. With facilities in Europe and North America, ReciBioPharm is ready to support your discovery, clinical and commercial cell and gene therapy ATMPs.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

ReciBioPharm